UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000019132
Receipt number R000022119
Scientific Title Effects of rush immunotherapy for Dermatophagoides
Date of disclosure of the study information 2015/09/28
Last modified on 2022/04/03 09:56:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of rush immunotherapy for Dermatophagoides

Acronym

Effects of rush immunotherapy for Dermatophagoides

Scientific Title

Effects of rush immunotherapy for Dermatophagoides

Scientific Title:Acronym

Effects of rush immunotherapy for Dermatophagoides

Region

Japan


Condition

Condition

Allergic rhinitis, Bronchial asthma

Classification by specialty

Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We compare the Effects of rush immunotherapy for Dermatophagoides between treatment group and control group

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

QOL or Symptoms of allergic rhinitis or bronchial asthma (after one year)

Key secondary outcomes

QOL or Symptoms of allergic rhinitis or bronchial asthma (per visit)
Specific IgE, basophil activation test, specific IgG4, Forced Oscillation Technique, lung function, Fractional exhaled nitric oxide, and so on


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

blood test(pre, 1week, 1month, 3month, half-year, one-year, 10ml per time), bronchial challenge test(pre, one-year), spirometry(every visit, up to one-year), FeNO(every visit, up to one-year), Forced Oscillation Technique(every visit, up to one-year)

Interventions/Control_2

blood test(pre, one-year, 10ml per time), bronchial challenge test(pre, one-year), spirometry(every visit, up to one-year), FeNO(every visit, up to one-year), Forced Oscillation Technique(every visit, up to one-year)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

18 years-old >

Gender

Male and Female

Key inclusion criteria

1. >=5 years old, <18 years old
2. Positive with specific IgE of Dermatophagoides
3. Patient with allergic rhinitis or bronchial asthma(atopic)
4. No current other immunotherapy
5. In bronchial asthma: %FEV1.0>70, using ICS, not using omalizumab, mild intermittent asthma

Key exclusion criteria

no

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomoyuki Asaumi

Organization

Sagamihara National Hospital

Division name

Pediatrics

Zip code


Address

18-1 Sakuradai, Minamiku, Sagamihara, Kanagawa

TEL

042-742-8311

Email

Ocean19oranges@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Tomoyuki Asaumi

Organization

Sagamihara National Hospital

Division name

Pediatrics

Zip code


Address

18-1 Sakuradai, Minamiku, Sagamihara, Kanagawa

TEL

042-742-8311

Homepage URL


Email

Ocean19oranges@yahoo.co.jp


Sponsor or person

Institute

Sagamihara National Hospital

Institute

Department

Personal name



Funding Source

Organization

Consumer Affairs Agency

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

相模原病院


Other administrative information

Date of disclosure of the study information

2015 Year 09 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 08 Month 01 Day

Date of IRB

2015 Year 08 Month 01 Day

Anticipated trial start date

2015 Year 08 Month 01 Day

Last follow-up date

2020 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 09 Month 28 Day

Last modified on

2022 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022119


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name